North America Molecular Diagnostics Market Size, Share & Trends Report

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030

Report ID: GVR-1-68038-073-6
Number of Report Pages: 120
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Market Segmentation

North America Molecular Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
- Instruments
- Reagents
- Others
North America Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
- Point-of-Care
- Self-test or Over the Counter
- Central Laboratories
North America Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
- Polymerase Chain Reaction (PCR)
  - PCR, by Type
    - Multiplex PCR
    - Other PCR
  - PCR, by Procedure
    - Nucleic Acid Extraction
    - Others
  - PCR, by Product
    - Instruments
    - Reagents
    - Others
- In Situ Hybridization
  - Instruments
  - Reagents
  - Others
- Isothermal Nucleic Acid Amplification Technology (INAAT)
  - Instruments
  - Reagents
  - Others
- Chips and Microarrays
  - Instruments
  - Reagents
  - Others
- Mass spectroscopy
  - Instruments
  - Reagents
  - Others
- Sequencing
  - Instruments
  - Reagents
  - Others
- Transcription Mediated Amplification (TMA)
  - Instruments
  - Reagents
  - Others
- Others
  - Instruments
  - Reagents
  - Others
North America Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
- Oncology
  - Breast Cancer
  - Prostate Cancer
  - Colorectal Cancer
  - Cervical Cancer
  - Kidney Cancer
  - Liver Cancer
  - Blood Cancer
  - Lung Cancer
  - Other Cancer
- Pharmacogenomics
- Infectious Diseases
  - Methicillin-resistant Staphylococcus Aureus (MRSA)
  - Clostridium Difficile
  - Vancomycin-resistant Enterococci (VRE)
  - Carbapenem-resistant Bacteria
  - Flu
  - Respiratory Syncytial Virus (RSV)
  - Candida
  - Tuberculosis and Drug-resistant TBA
  - Meningitis
  - Gastrointestinal Panel Testing
  - Chlamydia
  - Gonorrhea
  - HIV
  - Hepatitis C
  - Hepatitis B
  - Other Infectious Disease
- Genetic Testing
  - Newborn Screening
  - Predictive and Presymptomatic Testing
  - Other Genetic Testing
- Neurological Disease
- Cardiovascular Disease
- Microbiology
- Others
North America Molecular Diagnostics Market Regional Outlook (USD Million, 2018 - 2030)
- U.S.
  - U.S. Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
    - Instruments
    - Reagents
    - Others
  - U.S. Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
    - Point-of-Care
    - Self-test or Over the Counter
    - Central Laboratories
  - U.S. Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
    - Polymerase Chain Reaction (PCR)
      - PCR, by Type
        
        Multiplex PCR
        
        Other PCR
      - PCR, by Procedure
        
        Nucleic Acid Extraction
        
        Others
      - PCR, by Product
        
        Instruments
        
        Reagents
        
        Others
    - In Situ Hybridization
      - Instruments
      - Reagents
      - Others
    - Isothermal Nucleic Acid Amplification Technology (INAAT)
      - Instruments
      - Reagents
      - Others
    - Chips and Microarrays
      - Instruments
      - Reagents
      - Others
    - Mass spectroscopy
      - Instruments
      - Reagents
      - Others
    - Sequencing
      - Instruments
      - Reagents
      - Others
    - Transcription Mediated Amplification (TMA)
      - Instruments
      - Reagents
      - Others
    - Others
      - Instruments
      - Reagents
      - Others
  - U.S. Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
    - Oncology
      - Breast Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Kidney Cancer
      - Liver Cancer
      - Blood Cancer
      - Lung Cancer
      - Other Cancer
    - Pharmacogenomics
    - Infectious Diseases
      - Methicillin-resistant Staphylococcus Aureus (MRSA)
      - Clostridium Difficile
      - Vancomycin-resistant Enterococci (VRE)
      - Carbapenem-resistant Bacteria
      - Flu
      - Respiratory Syncytial Virus (RSV)
      - Candida
      - Tuberculosis and Drug-resistant TBA
      - Meningitis
      - Gastrointestinal Panel Testing
      - Chlamydia
      - Gonorrhea
      - HIV
      - Hepatitis C
      - Hepatitis B
      - Other Infectious Disease
    - Genetic Testing
      - Newborn Screening
      - Predictive and Presymptomatic Testing
      - Other Genetic Testing
    - Neurological Disease
    - Cardiovascular Disease
    - Microbiology
    - Others
- Canada
  - Canada Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
    - Instruments
    - Reagents
    - Others
  - Canada Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
    - Point-of-Care
    - Self-test or Over the Counter
    - Central Laboratories
  - Canada Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
    - Polymerase Chain Reaction (PCR)
      - PCR, by Type
        
        Multiplex PCR
        
        Other PCR
      - PCR, by Procedure
        
        Nucleic Acid Extraction
        
        Others
      - PCR, by Product
        
        Instruments
        
        Reagents
        
        Others
    - In Situ Hybridization
      - Instruments
      - Reagents
      - Others
    - Isothermal Nucleic Acid Amplification Technology (INAAT)
      - Instruments
      - Reagents
      - Others
    - Chips and Microarrays
      - Instruments
      - Reagents
      - Others
    - Mass spectroscopy
      - Instruments
      - Reagents
      - Others
    - Sequencing
      - Instruments
      - Reagents
      - Others
    - Transcription Mediated Amplification (TMA)
      - Instruments
      - Reagents
      - Others
    - Others
      - Instruments
      - Reagents
      - Others
  - Canada Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
    - Oncology
      - Breast Cancer
      - Prostate Cancer
      - Colorectal Cancer
      - Cervical Cancer
      - Kidney Cancer
      - Liver Cancer
      - Blood Cancer
      - Lung Cancer
      - Other Cancer
    - Pharmacogenomics
    - Infectious Diseases
      - Methicillin-resistant Staphylococcus Aureus (MRSA)
      - Clostridium Difficile
      - Vancomycin-resistant Enterococci (VRE)
      - Carbapenem-resistant Bacteria
      - Flu
      - Respiratory Syncytial Virus (RSV)
      - Candida
      - Tuberculosis and Drug-resistant TBA
      - Meningitis
      - Gastrointestinal Panel Testing
      - Chlamydia
      - Gonorrhea
      - HIV
      - Hepatitis C
      - Hepatitis B
      - Other Infectious Disease
    - Genetic Testing
      - Newborn Screening
      - Predictive and Presymptomatic Testing
      - Other Genetic Testing
    - Neurological Disease
    - Cardiovascular Disease
    - Microbiology
    - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.